my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Cenix BioScience GmbH announced that it has signed a research agreement with Heidelberg-based SYGNIS Bioscience GmbH & Co. KG. Under the research agreement’s first assignment to advance the SYGNIS KIBRA project, Cenix will apply its long-standing expertise in combining high content screening with ge more
Exonhit announced that it has entered into a research agreement with Pfizer Inc. for the identification of new Alzheimer’s disease (AD) biomarkers using Exonhit’s Genome-Wide SpliceArray™ (GWSA) platform.As part of the agreement, the two companies will jointly conduct a pilot study using Exonhit’s G more
Cenix BioScience GmbH and ugichem GmbH announced that they have entered into a research agreement to advance the latter’s technology platform.Under the agreed work plan, Cenix will apply its long-standing expertise in combining gene silencing analyses with high content screening in cultured cells. C more
In science news around the world this week, the U.K. is boosting its science budget slightly, tiger numbers may be up in India, oceanographers are scouring the sea floor off Brazil's northeast coast for the flight recorders from a doomed 2009 flight, a venerated volcano has inspired a rare attempt a more
ImmunoVaccine Technologies Inc. (IMV, formerly Rhino Resources Inc.) is a biotechnology company engaged in the development of high potential vaccines used for human health. The company develops its products based on its unique patented vaccine delivery and enhancement technology, the DepoVax platfor more
OncoTherapy Science, Inc. (OTS) is a publicly held biotechnology company. It is engaged in the provision of anti-cancer medicines with higher efficacy and a minimum risk. The company utilizes two core technologies to discover and develop drug candidates, namely, laser micro-beam microdissection (LMM more
MabCure Inc. (MabCure), formerly Smartec Holdings Inc. is a development stage medical device company engaged in the development of monoclonal antibodies for the in-vitro diagnostic markets. The company develops new technologies for the early detection of cancer as well antibodies and drugs that atta more
Highly innovative Molecular Biology Solutions for Electroporation, PCR, DNA Buccal Swabs, DNA Isolation Kits and other Life Science Technologies. The Cell Projects ™ product division supplies quality plastic and chemical enabling kits for: Electroporation Transfection PCR HTS Isohelix DNA Isolation more
Printable version About us Our Products R & D Partnerships People Investor & Media Transgene is a fully integrated biopharmaceutical company that designs and develops cutting-edge immunotherapeutic products to treat cancers and chronic infectious diseases. Our expertise covers all stages of product more
A A Home About Us Investors Management Board of Directors Scientific Advisory Board Technologies Antibodies Overview Intellectual Property Glossary Partnering Press Room Career Contact Maps & Directions Basel Site Maps & Directions Jena Site Press Room Recent news releases March 16, 2010: 4-Antibody more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
